Therefore, we speculated that a knock-in expression of this active mutant Parkin might provide protection in cardiac disease models in vivo. We previously established a mouse model of survival endotoxemia, in which cardiomyopathy is induced by a toxic dose of LPS (Sun et al., 2018a; Sun et al., 2018b). Here, PRKN is linked to heart disorder.